Transcription of INDICATIONS AND USAGE------------------------
{{id}} {{{paragraph}}}
HIGHLIGHTS OF prescribing INFORMATIONT hese highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for (dapagliflozin) tablets, for oral useInitial Approval: 2014-----------------------------INDICAT IONS AND USAGE-----------------------------FARXIG A is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1)Limitation of use: Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis. ( )---------------------------DOSAGE AND ADMINISTRATION------------------------- The recommended starting dose is 5 mg once daily, taken in the morning, with or without food.
HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use FARXIGA . safely and effectively. See full prescribing information for FARXIGA.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}